Malignant Colorectal Polyps: Are Pathology Reports Sufficient for Decision Making?
Journal
Surgical laparoscopy, endoscopy & percutaneous techniques
ISSN: 1534-4908
Titre abrégé: Surg Laparosc Endosc Percutan Tech
Pays: United States
ID NLM: 100888751
Informations de publication
Date de publication:
01 Feb 2023
01 Feb 2023
Historique:
received:
29
04
2022
accepted:
24
10
2022
pubmed:
3
2
2023
medline:
9
2
2023
entrez:
2
2
2023
Statut:
epublish
Résumé
This study aims to assess the completeness of pathology reports of T1 colorectal cancers from different healthcare centers and the change of treatment decision after reevaluation of the polyps. In this single-center retrospective cohort study, several pathology reports of endoscopically excised malignant colorectal polyps at diverse healthcare centers in Turkey were reassessed at a comprehensive cancer center in Istanbul. Reassessment was mainly focused on core elements such as the size of invasive carcinoma, histologic type and grade, tumor extension, surgical margin (deep and mucosal), and lymphovascular invasion. Sixty-seven endoscopically resected malignant polyps were analyzed. The mean age of patients was 62.2 years and 38 (58%) patients were males. Tumor size, histologic type and grade, surgical margin (deep and mucosal), and lymphovascular invasion were reported in 11%, 100%, 31%, 9%, and 19%, respectively. All 5 prognostic factors were reported only in 1 (1.5%) pathology report. Because of the missing (incomplete) data, the pathologic examination of 59 (88%) patients was determined to be inadequate to make an accurate treatment decision. Several variables are not considered and frequently missing for decision-making, suggesting the reassessment of the specimen by a second pathologist at a high-volume comprehensive cancer center.
Identifiants
pubmed: 36729667
doi: 10.1097/SLE.0000000000001131
pii: 00129689-990000000-00077
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
22-26Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177–193.
Bosch S, Teerenstra S, de Wilt J, et al. Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions. Endoscopy. 2013;45:827–841.
Chang H-C, Huang S-C, Chen J-S, et al. Risk factors for lymph node metastasis in pT1 and pT2 rectal cancer: a single-institute experience in 943 patients and literature review. Ann Surg Oncol. 2012;19:2477–2484.
Ricciardi R, Madoff RD, Rothenberger DA, et al. Population-based analyses of lymph node metastases in colorectal cancer. Clin Gastroenterol Hepatol. 2006;4:1522–1527.
Neilson LJ, Rutter MD, Saunders BP, et al. Assessment and management of the malignant colorectal polyp. Frontline Gastroenterol. 2015;6:117–126.
Office for National Statistics. Cancer registration statistics, 2012. Available at: http://www.ons.gov.uk/ons/dcp171778_367563.pdf . Accessed December 11, 2014.
Williams JG, Pullan RD, Hill J, et al. Management of the malignant colorectal polyp: ACPGBI position statement. Colorectal Dis. 2013;15(Suppl 2):1–38.
National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology; Colon Cancer (v.3.2018). Available at: https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf . Accessed April 10, 2018.
Gimon TI, Dykstra MA, Chezar K, et al. Malignant colorectal polyp pathology: are we getting sufficient information to make decisions? Dis Colon Rectum. 2020;63:135–142.
Wang LM, Guy R, Fryer E, et al. The Ueno method for substaging pT1 colorectal adenocarcinoma by depth and width measurement: an interobserver study. Colorectal Dis. 2015;17:674–681.
Patel N, Vyas M, Celli R, et al. Adverse histologic features in colorectal nonpedunculated malignant polyps with nodal metastasis. Am J Surg Pathol. 2020;44:241–246.
Hagen CE, Farooq A. Histologic evaluation of malignant polyps and low-stage colorectal carcinoma. Arch Pathol Lab Med. 2019;143:1450–1454.
Swan MP, Bourke MJ, Alexander S, et al. Large refractory colonic polyps: is it time to change our practice? A prospective study of the clinical and economic impact of a tertiary referral colonic mucosal resection and polypectomy service (with videos). Gastrointest Endosc. 2009;70:1128–1136.
College of American Pathologists. Protocol for the Examination of Specimens From Patients With Primary Carcinoma of the Colon and Rectum. 2017. Available at: https://documents.cap.org/protocols/cp-colon-rectum-2017-v4000.pdf . Accessed September 1, 2019
Berg KB, Telford JJ, Gentile L, et al. Re-examining the 1-mm margin and submucosal depth of invasion: a review of 216 malignant colorectal polyps. Virchows Arch. 2020;476:863–870.
Egashira Y, Yoshida T, Hirata I, et al. Analysis of pathological risk factors for lymph node metastasis of submucosal invasive colon cancer. Mod Pathol. 2004;17:503–511.
Pai RK, Chen Y, Jakubowski MA, et al. Colorectal carcinomas with submucosal invasion (pT1): analysis of histopathological and molecular factors predicting lymph node metastasis. Mod Pathol. 2016;30:113–122.
Richards C, Leitch F, Horgan P, et al. A systematic review of POSSUM and its related models as predictors of post-operative mortality and morbidity in patients undergoing surgery for colorectal cancer. J Gastrointest Surg. 2010;14:1511–1520.
Dano H, Baldin P, Demetter P, et al. Guidelines for an optimal management of a malignant colorectal polyp. What is essential in a pathology report? Acta Gastroenterol Belg. 2020;83:53–59.
Urbanowicz M, Grabsch HI, Fiteni F, et al. An international survey-based study on colorectal cancer pathology reporting-guidelines versus local practice. Virchows Arch. 2018;473:697–708.
Rex DK, Shaukat A, Wallace MB. Optimal management of malignant polyps, from endoscopic assessment and resection to decisions about surgery. Clin Gastroenterol Hepatol. 2019;17:1428–1437.
Kitajima K, Fujimori T, Fujii S, et al. Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study. J Gastroenterol. 2004;39:534–543.
Matsuda T, Fukuzawa M, Uraoka T, et al. Risk of lymph node metastasis in patients with pedunculated type early invasive colorectal cancer: a retrospective multicenter study. Cancer Sci. 2011;102:1693–1697.
Ueno H, Mochizuki H, Hashiguchi Y, et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology. 2004;127:385–394.
Kawachi H, Eishi Y, Ueno H, et al. A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study. Mod Pathol. 2015;28:872–879.
Bujanda L, Cosme A, Gil I, et al. Malignant colorectal polyps. World J Gastroenterol. 2010;16:3103–3111.